Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial

Roslyn A Stone, R Harsha Rao, Mary Ann Sevick, Chunrong Cheng, Linda J Hough, David S Macpherson, Carol M Franko, Rebecca A Anglin, D Scott Obrosky, Frederick R Derubertis, Roslyn A Stone, R Harsha Rao, Mary Ann Sevick, Chunrong Cheng, Linda J Hough, David S Macpherson, Carol M Franko, Rebecca A Anglin, D Scott Obrosky, Frederick R Derubertis

Abstract

OBJECTIVE We compared the short-term efficacy of home telemonitoring coupled with active medication management by a nurse practitioner with a monthly care coordination telephone call on glycemic control in veterans with type 2 diabetes and entry A1C > or =7.5%. RESEARCH DESIGN AND METHODS Veterans who received primary care at the VA Pittsburgh Healthcare System from June 2004 to December 2005, who were taking oral hypoglycemic agents and/or insulin for > or =1 year, and who had A1C > or =7.5% at enrollment were randomly assigned to either active care management with home telemonitoring (ACM+HT group, n = 73) or a monthly care coordination telephone call (CC group, n = 77). Both groups received monthly calls for diabetes education and self-management review. ACM+HT group participants transmitted blood glucose, blood pressure, and weight to a nurse practitioner using the Viterion 100 TeleHealth Monitor; the nurse practitioner adjusted medications for glucose, blood pressure, and lipid control based on established American Diabetes Association targets. Measures were obtained at baseline, 3-month, and 6-month visits. RESULTS Baseline characteristics were similar in both groups, with mean A1C of 9.4% (CC group) and 9.6% (ACM+HT group). Compared with the CC group, the ACM+HT group demonstrated significantly larger decreases in A1C at 3 months (1.7 vs. 0.7%) and 6 months (1.7 vs. 0.8%; P < 0.001 for each), with most improvement occurring by 3 months. CONCLUSIONS Compared with the CC group, the ACM+HT group demonstrated significantly greater reductions in A1C by 3 and 6 months. However, both interventions improved glycemic control in primary care patients with previously inadequate control.

Figures

Figure 1
Figure 1
Dot plots of the primary outcome measures (A1C, weight, systolic blood pressure, diastolic blood pressure, cholesterol, HDL, LDL, and triglycerides) at baseline, 3 months, and 6 months by treatment group. ●, ACM + HT group; ○, CC group. Time-specific mean values are connected by solid black lines for the ACM + HT group and dotted lines for the CC group.

References

    1. Maciejewski ML, Maynard C: Diabetes-related utilization and costs for inpatient and outpatient services in the Veterans Administration. Diabetes Care 2004;27:B69–B73
    1. Miller DR, Safford MM, Pogach LM: Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 2004;27:B10–B21
    1. VHA Office of Quality and Performance. Unpublished data.
    1. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holmann RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000;321:405–412
    1. UKPDS Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854–865 [erratum 1998;352:1558]
    1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–987
    1. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559
    1. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560–2572
    1. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD: VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129–139
    1. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA: 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577–1589
    1. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643–2653
    1. Currell R, Urquhart C, Wainwright P, Lewis R: Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2009;3:1–37
    1. Bergenstal RM, Anderson RL, Bina DM, Johnson ML, Davidson JL, Solarz-Johnson B, Kendall DM: Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control. Diabetes Technol Ther 2005;7:241–247
    1. Biermann E, Dietrich W, Rihl J, Standl E: Are there time and cost savings by using telemanagement for patients on intensified insulin therapy? A randomized, controlled trial. Comput Methods Programs Biomed 2002;69:137–146
    1. Chase HP, Pearson JA, Wightman C, Roberts MD, Oderberg AD, Garg SK: Modem transmission of glucose values reduces the costs and need for clinic visits. Diabetes Care 2003;26:1475–1479
    1. Marrero DG, Vandagriff JL, Kronz K, Fineberg NS, Golden MP, Gray D, Orr DP, Wright JC, Johnson NB: Using telecommunication technology to manage children with diabetes: the Computer-Linked Outpatient Clinic (CLOC) Study. Diabetes Educ 1995;21:313–319
    1. Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC: Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care 2004;27:1088–1094
    1. Shea S, Weinstock RS, Teresi JA, Palmas W, Starren J, Cimino JJ, Lai AM, Field L, Morin PC, Goland R, Izquierdo RE, Ebner S, Silver S, Petkova E, Kong J, Eimicke JP: IDEATel Consortium. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse medically underserved patients with diabetes mellitus: 5 year results of the IDEATel study. J Am Med Inform Assoc 2009;16:446–456
    1. Vahatalo MA, Virtamo HE, Viikari JS, Ronnemaa T: Cellular phone transferred self blood glucose monitoring: prerequisites for positive outcome. Pract Diabetes Int 2004;21:192–194
    1. ViterionNET TeleHealthCare Network [article online]. Available from Accessed 15 January 2009
    1. Royston P: Multiple imputation of missing values: update of ice. Stata J 2005;5:527–536
    1. StataCorp. STATA Statistical Software, release 9 College Station, TX, StataCorp, 2005
    1. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM: Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002;25:1159–1171
    1. Sarol JN, Jr, Nicodemus NA, Jr, Tan KM, Grava MB: Self-monitoring of blood glucose as part of a multicomponent therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004). Curr Med Res Opin 2005;21:173–184
    1. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM: Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005;28:1510–1517

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa